# Subcutaneous Testosterone Project

> **NCT02229617** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 14 (actual)

## Conditions studied

- Gender Dysphoria

## Interventions

- **DRUG:** Subcutaneous testosterone

## Key facts

- **NCT ID:** NCT02229617
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02229617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02229617, "Subcutaneous Testosterone Project". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02229617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*